Sachin Perera

Modern paradigms for prostate cancer detection and management

N. Lawrentschuk, D. Murphy, M. Frydenberg, 2022, The Medical journal of Australia.

Active surveillance versus nonradical treatment for low-risk men with prostate cancer: a review

N. Lawrentschuk, D. Murphy, J. O'Brien, 2022, Prostate international.

Active surveillance versus enzalutamide for low‐risk prostate cancer – was it really a trial we needed?

N. Lawrentschuk, N. Corcoran, D. Murphy, 2022, BJU international.